BIOLARGO, INC. (51) | Uncategorized (9)
Recent Contracts
-
Engagement Extension Agreement dated as of March 22, 2022 between BioLargo, Inc. and Charles K. Dargan, II
(Filed With SEC on March 24, 2022)
-
Agreement dated March 1, 2022, by and between Scion Solutions, LLC, Clyra Medical Technologies, Inc., and BioLargo, Inc
(Filed With SEC on March 8, 2022)
-
Agreement dated March 3, 2022, by and between Clyra Medical Technologies, Inc., and BioLargo, Inc
(Filed With SEC on March 8, 2022)
-
Engagement Extension Agreement dated as of March 18, 2021 between BioLargo, Inc. and Charles K. Dargan, II
(Filed With SEC on March 19, 2021)
-
Engagement Extension Agreement dated as of February 23, 2020 between BioLargo, Inc. and Charles K. Dargan, II
(Filed With SEC on February 27, 2020)
-
Lock-Up Agreement dated May 28, 2019
(Filed With SEC on June 24, 2019)
-
Engagement Extension Agreement dated as of January 16, 2019 between BioLargo, Inc. and Charles K. Dargan, II
(Filed With SEC on January 18, 2019)
-
Option to purchase common stock issued to Charles K. Dargan dated December 31, 2017
(Filed With SEC on January 3, 2018)
-
Engagement Extension Agreement dated as of December 31, 2017 between BioLargo, Inc. and Charles K. Dargan, II
(Filed With SEC on January 3, 2018)